Because development of acute renal failure is one of the most potent predic
tors of outcome in cardiac surgery patients, the prevention of renal dysfun
ction is of utmost importance in perioperative care. In a double-blind rand
omized controlled trial, the effectiveness of dopamine or furosemide in pre
vention of renal impairment after cardiac surgery was evaluated. A total of
126 patients with preoperatively normal renal function undergoing elective
cardiac surgery received a continuous infusion of either "renal-dose" dopa
mine (2 mu g/kg per min) (group D), furosemide (0.5 mu g/kg per min) (group
F), or isotonic sodium chloride as placebo (group P), starting at the begi
nning of surgery and continuing for 48 h or until discharge from the intens
ive care unit, whichever came first. Renal function parameters and the maxi
mal increase of serum creatinine above baseline value within 48 h (Delta Cr
ea(max)) were determined. The increase in plasma creatinine was twice as hi
gh in group F as in groups D and P (P < 0.01). Acute renal injury (defined
as Delta Crea(max) > 0.5 mg/dl) occurred more frequently in group F (six of
41 patients) than in group D (one of 42) and group P (zero of 40) (P < 0.0
1). (The difference between group D and group P was not significant.) Creat
inine clearance was lower in group F (P < 0.05). Two patients in group F re
quired renal replacement therapy. The mean Volume of in fused fluids, blood
urea nitrogen, serum sodium, serum potassium, and osmolar- and free-water
clearance was similar in all groups. It was shown that continuous infusion
of dopamine for renal protection was ineffective and was not superior to pl
acebo in preventing postoperative dysfunction after cardiac surgery. In con
trast, continuous infusion of furosemide was associated with the highest ra
te of renal impairment. Thus, renal-dose dopamine is ineffective and furose
mide is even detrimental in the protection of renal dysfunction after cardi
ac surgery.